Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oxygen saturation, Platelet count, Presyncope, Protein total normal
Clinical narrative: injection site become red and hot; rapid heart rate; diagnosed with BPPV; felt like i was going to pass out; injection site become red and hot; NAUSEA; Dizziness/Light head; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness/Light head), VACCINATION SITE WARMTH (injection site become red and hot), TACHYCARDIA (rapid heart rate), VERTIGO POSITIONAL (diagnosed with BPPV) and PRESYNCOPE (felt like i was going to pass out) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A. and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cervical pap smear abnormal, Stress and Tooth extraction. Previously administered products included for Product used for unknown indication: tetanus vaccine on 18-Sep-2019. Concurrent medical conditions included Asthma, Drug allergy (ibuprofen), Alcohol use, Seasonal allergy and Cold intolerance. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (FLUTICASONE + SALMETEROL) from 10-Mar-2021 to an unknown date for Asthma, LORATADINE (CLARITINE), SALBUTAMOL (ALBUTEROL HFA), BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 08-Mar-2021, the patient experienced DIZZINESS (Dizziness/Light head) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE WARMTH (injection site become red and hot), TACHYCARDIA (rapid heart rate), VERTIGO POSITIONAL (diagnosed with BPPV), PRESYNCOPE (felt like i was going to pass out), VACCINATION SITE ERYTHEMA (injection site become red and hot) and NAUSEA (NAUSEA). The patient was treated with MECLOZINE HYDROCHLORIDE (ANTIVERT [MECLOZINE HYDROCHLORIDE]) (oral) for Nausea, at a dose of 25 mg three times a day; DEXAMETHASONE on 28-Mar-2021 at a dose of 8 mg; PARACETAMOL for Headache, at a dose of 1 dosage form and Physical therapy (occupational therapy) for Dizziness. At the time of the report, DIZZINESS (Dizziness/Light head) was resolving and VACCINATION SITE WARMTH (injection site become red and hot), TACHYCARDIA (rapid heart rate), VERTIGO POSITIONAL (diagnosed with BPPV), PRESYNCOPE (felt like i was going to pass out), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (injection site become red and hot) and NAUSEA (NAUSEA) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Blood creatinine (0.5-1.4 mg/dl): 0.8 mg/dl (normal) normal. On 16-Mar-2021, Blood glucose (70-110 mg/dl): 70 mg/dl (normal) normal. On 16-Mar-2021, Blood thyroid stimulating hormone: 1.230 mIU/L (normal) normal. On 16-Mar-2021, Platelet count: 246 (normal) normal. On 16-Mar-2021, White blood cell count: 3.74 liter (Low) low. On 22-Mar-2021, Audiogram: (normal) normal limits bilaterally and (normal) normal hearing. On 28-Mar-2021, Alanine aminotransferase (10-44): 83 (High) high. On 28-Mar-2021, Aspartate aminotransferase (10-40): 76 (abnormal) abnormal. On 28-Mar-2021, Blood alkaline phosphatase (55-135): 42 (abnormal) abnormal. On 28-Mar-2021, Blood pressure measurement: 119/78 mmHg (Inconclusive) inconclusive. On 28-Mar-2021, Body temperature: 98.1 (normal) normal. On 28-Mar-2021, Heart rate: 78 (normal) normal. On 28-Mar-2021, Mean cell haemoglobin: 26.8 (abnormal) abnormal. On 17-Sep-2021, Blood pressure measurement: 122/82 mmHg (Inconclusive) inconclusive. On 17-Sep-2021, Blood thyroid stimulating hormone: 1.732 mIU/L (normal) normal. On 17-Sep-2021, Heart rate: 55 (Inconclusive) inconclusive. On 17-Sep-2021, Oxygen saturation: 100 % (normal) normal. On 18-Sep-2021, Acoustic stimulation tests: (Positive) positive hearing loss. On 18-Sep-2021, Alanine aminotransferase (10-44): 18 (normal) normal. On 18-Sep-2021, Anion gap (8-16): 9 (normal) normal 9mmol/l. On 18-Sep-2021, Aspartate aminotransferase (10-40): 24 (normal) normal. On 18-Sep-2021, Blood albumin (3.5-5.2 mg/dl): 4.7 mg/dl (normal) normal. On 18-Sep-2021, Blood alkaline phosphatase (55-135): 41 (Low) low. On 18-Sep-2021, Blood bilirubin (0.1-1.0 mg/dl): 0.7 mg/dl (normal) normal. On 18-Sep-2021, Blood calcium (8.7-10.5 mg/dl): 10.1 mg/dl (normal) normal. On 18-Sep-2021, Blood chloride (95-110): 104 (normal) normal. On 18-Sep-2021, Blood cholesterol: 164 (normal) normal. On 18-Sep-2021, Blood creatinine (0.5-1.4 mg/dl): 0.8 mg/dl (normal) normal. On 18-Sep-2021, Blood glucose (70-110 mg/dl): 77 mg/dl (normal) normal. On 18-Sep-2021, Blood potassium (3.5-5.1): 4.1 (normal) normal. On 18-Sep-2021, Blood pressure measurement: 122/72 mmHg (Inconclusive) inconclusive. On 18-Sep-2021, Blood sodium (136-145): 139 (normal) normal. On 18-Sep-2021, Blood thyroid stimulating hormone: 1.230 mIU/L (normal) normal. On 18-Sep-2021, Blood triglycerides: 49 mg/dl (normal) normal. On 18-Sep-2021, Blood urea (6-20 mg/dl): 7 mg/dl (normal) normal. On 18-Sep-2021, Body temperature: 97.5 (normal) normal. On 18-Sep-2021, Glomerular filtration rate: 60 (normal) normal. On 18-Sep-2021, Haematocrit: 41.0 (normal) normal. On 18-Sep-2021, Haemoglobin: 12.9 (normal) normal. On 18-Sep-2021, High density lipoprotein: 66 mg/dl (normal) normal. On 18-Sep-2021, Low density lipoprotein: 88.2 mg/dl (normal) normal. On 18-Sep-2021, Mean cell volume: 85 (normal) normal. On 18-Sep-2021, Platelet count: 238 (normal) normal. On 18-Sep-2021, Protein total normal (6.0-8.4): 7.7 (normal) normal. On 18-Sep-2021, White blood cell count: 6.39 liter (normal) normal.         Treatment included Flonase and Zyrtec .steroid theropy  patient height 5ft 7inch lab test Dix-Hallpik .   This case was linked to MOD-2021-053039.   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: in fallow up patient demographic details medical history lab data was updated concomitant medicines and treatment medicines was updated newevents  was added and event out come of dizziness was updated from  unknown to recovering/resolving